Journal of Psychedelic Studies
May 28, 2026
Lev Korchagin, Jonathan Fridman, Mario Mikulincer et al.
Abstract Background and aims This study explores the factors influencing the use of drug-testing kits as a harm reduction strategy among recreational psychedelic users in Israel. Methods Using an online survey of 422 participants, we collected data on attitudes toward testing psychedelic substances, harm reduction attitudes in the context of testing kits, accessibility to testing kits, and...
Journal of psychopharmacology (Oxford, England)
April 21, 2025
Einat Karp Barnir, Zohar Rubinstein, Rany Abend et al.
7 citations
Emerging evidence indicates the therapeutic potential of psychedelic compounds for post-traumatic stress, yet the mechanisms mediating their effects remain unclear. Delineating the effect of psychedelics on traumatic memory formation could shed light on target therapeutic mechanisms. Here, we report on 343 adult survivors of a single, large-scale terrorist attack taking place during a festival...
Frontiers in Psychiatry
January 10, 2023
Jonina Rabinowitz, Raz Gross, Shaul Lev-Ran
15 citations
Objective Classic psychedelics (LSD, psilocybin, and peyote/mescaline) have been used to support addiction treatment in a variety of contexts ranging from ceremonial use to clinical trials. The aim of this study was to test the hypothesis that past naturalistic use of classic psychedelics would be associated with decreased prevalence of substance use disorder, when controlling for known...
Journal of Psychoactive Drugs
2023
Aviad Hadar, Jonathan David, Nadav Shalit et al.
93 citations
Psychedelics were used in the treatment of psychiatric conditions prior to their prohibition in the late 1960s. In the past three decades, there is a revived research interest in the therapeutic potential of psychedelic drugs with expected FDA approvals for treatment of various conditions. Given the exponential scientific growth of this field, we sought to characterize, analyze, and visualize...